Presentation TCT 2016

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

Presenter: Horst Sievert

October 30, 2016

REGISTER for free or LOG IN to view this content

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

Structural Heart

Presentation

TCT 2016

PFO/ASD

Up Next

Presentation TCT 2016

Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention According to Dissection/Re-entry vs Wire Escalation Techniques

Presenter: Lorenzo Azzalini

October 30, 2016

More slides +

Presentation TCT 2016

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in a Frequentist Framework!

Presenter: Stuart J. Pocock

October 30, 2016

Presentation TCT 2016

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in A Bayesian Framework!

Presenter: Scott Berry

October 30, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.